Cargando…
Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization
Human RNASET2 (hRNASET2) has been demonstrated to exert antiangiogenic and antitumorigenic effects independent of its ribonuclease capacity. We suggested that RNASET2 exerts its antiangiogenic and antitumorigenic activities via binding to actin and consequently inhibits cell motility. We focused her...
Autores principales: | Nesiel-Nuttman, Liron, Doron, Shani, Schwartz, Betty, Shoseyov, Oded |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341462/ https://www.ncbi.nlm.nih.gov/pubmed/25815360 |
Ejemplares similares
-
Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014) -
Human recombinant RNASET2: A potential anti-cancer drug
por: Roiz, Levava, et al.
Publicado: (2016) -
A novel Aaproach to increase cell wall saccharification for efficient biofuel production
por: Abramson, Miron, et al.
Publicado: (2011) -
Highly Charged Cellulose Nanocrystals Applied as A Water Treatment Flocculant
por: Morantes, Dana, et al.
Publicado: (2019) -
Mammalian mitochondrial RNAs are degraded in the mitochondrial intermembrane space by RNASET2
por: Liu, Peipei, et al.
Publicado: (2017)